G. Steven Burrill
An introduction to Burrill Venture Capital
Flash required to view this video. Download the latest version here
G. Steven BurrillNews
Biotech holds steady in January as broader markets head south February 01, 2010 | Press Release
Biotech gets back on track in November December 01, 2009 | Press Release
Biotech takes it on the chin in October November 02, 2009 | Press Release
See all NewsThe Burrill family of venture capital funds includes funds with more than $950 million under management. These funds were formed to capitalize on Burrill’s unique investment platform and the opportunities created by today’s intersection of the genomic/proteomic and biologic revolution, and capital market inefficiency occurring within the life science field.
Investment Process Burrill & Company invests in life science companies whose technologies and products are applicable across a wide range of life science sub-sectors. Investment Process | Submit A Business Plan Have a promising life sciences company that needs funding? Let us know if you think we might be a good match for you and submit a business plan. Submit A Business Plan | Limited Partners
Learn more |
